Metronidazole

* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

Metronidazole
Category Antibiotics
Catalog number BBF-04552
CAS 443-48-1
Molecular Weight 171.15
Molecular Formula C6H9N3O3
Purity >98%

Ordering Information

Catalog Number Size Price Stock Quantity
BBF-04552 500 g $439 In stock

Online Inquiry

Add to cart

Description

Metronidazole is a synthetic antibacterial and antiprotozoal agent of the nitroimidazole class. It is a limited spectrum antibiotic that has activity against anaerobic gram-positive and anaerobic gram-negative bacteria. It is also promisingly to be a radiation sensitizer for hypoxic cells.

Specification

Related CAS 69198-10-3 (mono-hydrochloride)
Synonyms Flagyl; Metronidazol; 2-Methyl-5-nitroimidazole-1-Ethanol; Novonidazol; 2-Methyl-5-nitro-1H-imidazole-1-Ethanol; Anagiardil; Arilin; Bayer 5360; Cimetrol 500LPCI; Clont; Deflamon; Dentamet gel; Efloran; Elyzol; Flagesol; Flagil; 1-(2-Hydroxyethyl)-2-methyl-5-nitroimidazole; NSC 50364; NSC 69587; Nidazole
Storage Store in a well - closed container, protected from light.
IUPAC Name 2-(2-methyl-5-nitroimidazol-1-yl)Ethanol
Canonical SMILES CC1=NC=C(N1CCO)[N+](=O)[O-]
InChI InChI=1S/C6H9N3O3/c1-5-7-4-6(9(11)12)8(5)2-3-10/h4,10H,2-3H2,1H3
InChI Key VAOCPAMSLUNLGC-UHFFFAOYSA-N
Source Synthetic

Properties

Appearance White to pale yellow powder
Antibiotic Activity Spectrum Gram-positive bacteria; Gram-negative bacteria; Parasites
Boiling Point 405.4°C at 760 mmHg
Melting Point 156-158°C
Density 1.45 g/cm3
Solubility Slightly soluble in DMSO, Methanol
LogP -0.02

Toxicity

Carcinogenicity 2B, possibly carcinogenic to humans.
Mechanism Of Toxicity Metronidazole is a prodrug. Unionized metronidazole is selective for anaerobic bacteria due to their ability to intracellularly reduce metronidazole to its active form. This reduced metronidazole then covalently binds to DNA, disrupt its helical structure, inhibiting bacterial nucleic acid synthesis and resulting in bacterial cell death.
Toxicity LD50 = 500 mg/kg/day (orally in rat).

Reference Reading

1.Antibiotic resistance and CYP2C19 polymorphisms affect the efficacy of concomitant therapies for Helicobacter pylori infection: an open-label, randomized, single-centre clinical trial.
Hong J1, Shu X1, Liu D2, Zhu Y1, Xie C2, Xie Y2, Zhang K2, Wang A1, Xiong H1, Zeng H3, Yu H3, Ma J4, Chen Y4, Zhu X1, Lu N5. J Antimicrob Chemother. 2016 Apr 21. pii: dkw118. [Epub ahead of print]
OBJECTIVES: We evaluate the efficacy of concomitant therapy for Helicobacter pylori infection and the associated factors that influence it in China, where it has not previously been investigated.
2.Water Sources in a Zoological Park Harbor Genetically Diverse Strains of Clostridium Perfringens Type A with Decreased Susceptibility to Metronidazole.
Álvarez-Pérez S1, Blanco JL2,3, Peláez T4,5, Martínez-Nevado E6, García ME1. Microb Ecol. 2016 Apr 26. [Epub ahead of print]
The presence of Clostridium perfringens in water is generally regarded as an indicator of fecal contamination, and exposure to waterborne spores is considered a possible source of infection for animals. We assessed the presence and genetic diversity of C. perfringens in water sources in a zoological park located in Madrid (Spain). A total of 48 water samples from 24 different sources were analyzed, and recovered isolates were toxinotyped, genotyped by fluorophore-enhanced repetitive polymerase chain reaction (rep-PCR) fingerprinting and tested for antimicrobial susceptibility. C. perfringens was recovered from 43.8 % of water samples and 50 % of water sources analyzed. All isolates (n = 70) were type A and 42.9 % were β2-toxigenic (i.e., cpb2+), but none contained the enterotoxin-encoding gene (cpe). Isolates belonged to 15 rep-PCR genotypes and most genetic diversity (88 %) was distributed among isolates obtained from the same sample. Most isolates displayed intermediate susceptibility (57.
3.Characterization of Antimicrobial Agent Loaded Eudragit RS Solvent Exchange-Induced In Situ Forming Gels for Periodontitis Treatment.
Phaechamud T1, Jantadee T2, Mahadlek J3, Charoensuksai P4, Pichayakorn W5. AAPS PharmSciTech. 2016 Apr 26. [Epub ahead of print]
Eudragit RS (ERS), a quaternary polyacrylate positively charged polymer, exhibits a very low permeability and swells in aqueous media independently of pH without dissolving. Owing to its high solubility in N-methyl pyrrolidone (NMP), it was interesting to apply as polymer matrix for solvent-exchanged in situ forming gel. The aim of this research was to prepare in situ forming gels from ERS to deliver the antimicrobial agents (doxycycline hyclate, metronidazole, and benzoyl peroxide) for periodontitis treatment. They were evaluated for viscosity and rheology, gel formation, syringeability, drug release, and antimicrobial activities. The solvent exchange between NMP and an external aqueous simulated gingival crevicular fluid stimulated the dissolved ERS transforming into the opaque rigid gel. Antimicrobial agent loaded ERS systems exhibited Newtonian flow with acceptable syringeability. The higher-loaded ERS promoted the more prolongation of drug release because of the retardation of water diffusion into the precipitated matrix.
4.A novel method for imaging the pharmacological effects of antibiotic treatment on Clostridium difficile.
Endres BT1, Bassères E1, Memariani A2, Chang L3, Alam MJ1, Vickers RJ4, Kakadiaris IA2, Garey KW5. Anaerobe. 2016 Apr 20. pii: S1075-9964(16)30040-3. doi: 10.1016/j.anaerobe.2016.04.013. [Epub ahead of print]
Clostridium difficile is a significant cause of nosocomial-acquired infection that results in severe diarrhea and can lead to mortality. Treatment options for C. difficile infection (CDI) are limited, however, new antibiotics are being developed. Current methods for determining efficacy of experimental antibiotics on C. difficile involve antibiotic killing rates and do not give insight into the drug's pharmacologic effects. Considering this, we hypothesized that by using scanning electron microscopy (SEM) in tandem to drug killing curves, we would be able to determine efficacy and visualize the phenotypic response to drug treatment. To test this hypothesis, supraMIC kill curves were conducted using vancomycin, metronidazole, fidaxomicin, and ridinilazole. Following collection, cells were either plated or imaged using a scanning electron microscope (SEM). Consistent with previous reports, we found that the tested antibiotics had significant bactericidal activity at supraMIC concentrations.

Spectrum

Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive

Experimental Conditions

Ionization Mode: Positive
Ionization Energy: 70 eV
Chromatography Type: Gas Chromatography Column (GC)
Instrument Type: Single quadrupole, spectrum predicted by CFM-ID(EI)
Mass Resolution: 0.0001 Da
Molecular Formula: C6H9N3O3
Molecular Weight (Monoisotopic Mass): 171.0644 Da
Molecular Weight (Avergae Mass): 171.154 Da

LC-MS/MS Spectrum - LC-ESI-QTOF , positive

Experimental Conditions

Instrument Type: LC-ESI-QTOF
Ionization Mode: positive

Predicted LC-MS/MS Spectrum - 10V, Positive

Experimental Conditions

Ionization Mode: Positive
Collision Energy: 10 eV
Instrument Type: QTOF (generic), spectrum predicted by CFM-ID
Mass Resolution: 0.0001 Da
Molecular Formula: C6H9N3O3
Molecular Weight (Monoisotopic Mass): 171.0644 Da
Molecular Weight (Avergae Mass): 171.154 Da

Mass Spectrum (Electron Ionization)

1H NMR Spectrum

Experimental Conditions

Solvent: DMSO-d6
Instrument Type: JEOL
Nucleus: 1H
Frequency: 400 MHz
Chemical Shift Reference: TMS

Recommended Products

Bio Calculators

Stock concentration: *
Desired final volume: *
Desired concentration: *

L

* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2

* Total Molecular Weight:
g/mol
Tip: Chemical formula is case sensitive. C22H30N4O c22h30n40
g/mol
g

Recently viewed products

Online Inquiry

Verification code

Copyright © 2024 BOC Sciences. All rights reserved.

cartIcon
Inquiry Basket